Generation and characterization of a stable soluble guanylate cyclase-overexpressing CHO cell line

被引:21
作者
Becker, EM
Wunder, F
Kast, R
Robyr, C
Hoenicka, M
Gerzer, R
Schröder, H
Stasch, JP
机构
[1] Bayer AG, Inst Cardiovasc & Arteriosclerosis Res, D-42096 Wuppertal, Germany
[2] Bayer AG, Inst Chem, D-42096 Wuppertal, Germany
[3] DLR, Inst Aerosp Med, Cologne, Germany
[4] Univ Halle Wittenberg, Sch Pharm, Halle, Germany
来源
NITRIC OXIDE-BIOLOGY AND CHEMISTRY | 1999年 / 3卷 / 01期
关键词
soluble guanylate cyclase; cGMP; YC-1; CHO; nitric oxide;
D O I
10.1006/niox.1999.0207
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
A stably transfected soluble guanylate cyclase (sGC, alpha(1) and beta(1) subunits of the rat lung enzyme)overexpressing CHO cell line was generated for the characterization of different types of activators of the soluble guanylate cyclase. Polyclonal antibodies directed against both subunits of the rat enzyme were used to detect both subunits in the cytosol of the transfected CHO cells. We studied the effects of different nitric oxide (NO) donors like SNP and DEA/NO and, in particular, the direct, NO-independent stimulator of the soluble guanylate cyclase 3-(5'-hydroxymethyl-2'furyl)-1-benzyl indazole (YC-1), on intracellular guanosine 3',5'-cyclic monophosphate (cGMP) production. DEA/NO (0.01-3 mu M), SNP (1-10 mu M), and YC-1 (1-10 mu M) induced a concentration-dependent intracellular cGMP increase withmaximal effects of 16-fold (3 mu M DEA/NO), 8-fold (10 mu M SNP), and 6-fold (10 mu M YC-1) stimulation compared to controls, respectively. In addition, a synergistic effect of the combination of the NO donor and YC-1 could be observed with a maximal stimulation of 64-fold by SNP (10 mu M) and YC-1 (10 mu M). 1H-(1,2,4)-Oxadiazolo-(4,3-a)-6-bromoquinoxazin-1-one (ODQ, 10 mu M), a potent and selective inhibitor of sGC, inhibited both the single effects of NO donors [DEA/NO (3 mu M), 77%; SNP (3 mu M), 83%] and YC-1 [YC-1 (3 mu M), 82%], but moreover the synergistic effects between NO donors and YC-1 [DEA/NO (3 mu M) + YC-1 (3 mu M), 81%; SNP (3 mu M) + YC-1 (3 mu M), 89%] on intracellular cGMP production. In summary,we have generated a simple, sensitive, and useful bioassay method to characterize all types of sGC activators on the cellular level without the need of primary cell culture, several transfections, or purifying enzyme from biological materials. (C) 1999 Academic Press.
引用
收藏
页码:55 / 66
页数:12
相关论文
共 40 条
  • [1] BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
  • [2] Buechler W A, 1995, Adv Pharmacol, V34, P293
  • [3] EXPRESSION OF SOLUBLE GUANYLATE-CYCLASE ACTIVITY REQUIRES BOTH ENZYME SUBUNITS
    BUECHLER, WA
    NAKANE, M
    MURAD, F
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1991, 174 (01) : 351 - 357
  • [4] Ca2+-independent activation of the endothelial nitric oxide synthase in response to tyrosine phosphatase inhibitors and fluid shear stress
    Fleming, I
    Bauersachs, J
    Fisslthaler, B
    Busse, R
    [J]. CIRCULATION RESEARCH, 1998, 82 (06) : 686 - 695
  • [5] FOERSTERMANN U, 1986, Circulation Research, V58, P531
  • [6] Sensitizing soluble guanylyl cyclase to become a highly CO-sensitive enzyme
    Friebe, A
    Schultz, G
    Koesling, D
    [J]. EMBO JOURNAL, 1996, 15 (24) : 6863 - 6868
  • [7] Mechanism of YC-1-induced activation of soluble guanylyl cyclase
    Friebe, A
    Koesling, D
    [J]. MOLECULAR PHARMACOLOGY, 1998, 53 (01) : 123 - 127
  • [8] THE OBLIGATORY ROLE OF ENDOTHELIAL-CELLS IN THE RELAXATION OF ARTERIAL SMOOTH-MUSCLE BY ACETYLCHOLINE
    FURCHGOTT, RF
    ZAWADZKI, JV
    [J]. NATURE, 1980, 288 (5789) : 373 - 376
  • [9] GARTHWAITE J, 1995, MOL PHARMACOL, V48, P184
  • [10] SOLUBLE GUANYLATE-CYCLASE PURIFIED FROM BOVINE LUNG CONTAINS HEME AND COPPER
    GERZER, R
    BOHME, E
    HOFMANN, F
    SCHULTZ, G
    [J]. FEBS LETTERS, 1981, 132 (01) : 71 - 74